Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-26 Purchase |
2024-12-30 4:26 pm |
Opus Genetics Inc. | IRD | Magrath George Chief Executive Officer |
100,000 | $0.976 | $97,600 | 599,150 (Direct) |
View |
| 2024-11-21 Purchase |
2024-11-25 4:18 pm |
Opus Genetics Inc. | IRD | YERXA BENJAMIN R President |
10,000 | $0.9834 | $9,834 | 342,800 (Direct) |
View |
| 2024-11-15 Purchase |
2024-11-19 4:08 pm |
Opus Genetics Inc. | IRD | Magrath George Chief Executive Officer |
100,000 | $1.0116 | $101,158 | 492,950 (Direct) |
View |
| 2024-05-22 Purchase |
2024-05-24 4:07 pm |
Ocuphire Pharma Inc. | OCUP | Jayagopal Ashwath Chief Scientific & Dev. Ofc. |
3,500 | $1.765 | $6,178 | 78,500 (Direct) |
View |
| 2024-05-17 Purchase |
2024-05-21 4:18 pm |
Ocuphire Pharma Inc. | OCUP | Magrath George Chief Executive Officer |
5,000 | $1.7545 | $8,773 | 430,000 (Direct) |
View |
| 2024-03-21 Purchase |
2024-03-25 4:44 pm |
Ocuphire Pharma Inc. | OCUP | SCHACHLE JOSEPH K Chief Operating Officer |
2,000 | $2.05 | $4,100 | 2,000 (Direct) |
View |
| 2024-03-21 Purchase |
2024-03-25 4:40 pm |
Ocuphire Pharma Inc. | OCUP | Jhaveri Nirav S. Chief Financial Officer |
10,000 | $2.1 | $21,000 | 150,000 (Direct) |
View |
| 2024-03-18 Purchase |
2024-03-20 4:18 pm |
Ocuphire Pharma Inc. | OCUP | Magrath George Chief Executive Officer |
25,000 | $1.962 | $49,050 | 425,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-24 Option Award |
2025-03-26 4:10 pm |
N/A 2030-03-24 |
Opus Genetics Inc. | IRD | Magrath George Chief Executive Officer |
392,157 | $0 | 1,714,161 (Direct) |
View |
| 2025-03-24 Option Award |
2025-03-26 4:08 pm |
N/A 2030-03-24 |
Opus Genetics Inc. | IRD | Gallagher Cam Director |
784,314 | $0 | 1,645,675 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-17 8:56 pm |
N/A 2035-03-12 |
Opus Genetics Inc. | IRD | SCHACHLE JOSEPH K Chief Operating Officer |
52,500 | $0 | 107,000 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-17 8:54 pm |
N/A 2035-03-12 |
Opus Genetics Inc. | IRD | Zaremba Rabourn Amy SVP of Finance |
39,500 | $0 | 153,468 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-17 8:53 pm |
N/A 2035-03-12 |
Opus Genetics Inc. | IRD | Magrath George Chief Executive Officer |
330,697 | $0 | 1,260,544 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-17 8:52 pm |
N/A 2035-03-12 |
Opus Genetics Inc. | IRD | Jhaveri Nirav S. Chief Financial Officer |
52,500 | $0 | 246,793 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-17 8:50 pm |
N/A 2035-03-12 |
Opus Genetics Inc. | IRD | Jayagopal Ashwath Chief Scientific & Dev. Ofc. |
52,500 | $0 | 178,307 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-17 8:49 pm |
N/A 2035-03-12 |
Opus Genetics Inc. | IRD | Hoffmann Bernhard SVP of Corp. Dev. |
29,500 | $0 | 214,946 (Direct) |
View |
| 2025-02-13 Tax Withholding |
2025-02-18 4:05 pm |
N/A N/A |
Opus Genetics Inc. | IRD | Jhaveri Nirav S. Chief Financial Officer |
8,207 | $1.15 | 141,793 (Direct) |
View |
| 2025-02-13 Tax Withholding |
2025-02-18 4:04 pm |
N/A N/A |
Opus Genetics Inc. | IRD | Jayagopal Ashwath Chief Scientific & Dev. Ofc. |
5,193 | $1.15 | 73,307 (Direct) |
View |
| 2025-02-04 Tax Withholding |
2025-02-06 4:37 pm |
N/A N/A |
Opus Genetics Inc. | IRD | Zaremba Rabourn Amy SVP of Finance |
8,190 | $1.14 | 74,468 (Direct) |
View |
| 2025-02-04 Tax Withholding |
2025-02-06 4:35 pm |
N/A N/A |
Opus Genetics Inc. | IRD | Hoffmann Bernhard SVP of Corp. Dev. |
6,751 | $1.14 | 155,946 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:43 pm |
N/A N/A |
Opus Genetics Inc. | IRD | MANUSO JAMES S J Director |
50,222 | $0 | 182,259 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:42 pm |
N/A N/A |
Opus Genetics Inc. | IRD | Bennett Jean Director |
34,021 | $0 | 134,021 (Direct) |
View |
| 2024-12-23 Option Award |
2024-12-23 5:50 pm |
N/A N/A |
Opus Genetics Inc. | IRD | Magrath George Chief Executive Officer |
6,200 | $0 | 499,150 (Direct) |
View |
| 2024-11-07 Option Award |
2024-11-12 4:35 pm |
N/A N/A |
Opus Genetics Inc. | IRD | YERXA BENJAMIN R President |
332,800 | $0 | 332,800 (Direct) |
View |
| 2024-11-01 Tax Withholding |
2024-11-05 4:13 pm |
N/A N/A |
Opus Genetics Inc. | IRD | Magrath George Chief Executive Officer |
37,050 | $1.18 | 392,950 (Direct) |
View |
Ownership |
2024-10-29 5:10 pm |
N/A N/A |
Opus Genetics Inc. | IRD | Foundation Fighting Blindness Retinal Degeneration Fund Foundation Fighting Blindness Inc. See Remarks |
0 | $0 | 2,571,679 (Direct) |
View |
| 2024-10-22 Option Award |
2024-10-24 5:59 pm |
N/A 2034-10-21 |
Opus Genetics Inc. | IRD | Graves Adrienne L Director |
172,874 | $0 | 172,874 (Direct) |
View |
| 2024-10-22 Option Award |
2024-10-24 5:56 pm |
N/A 2034-10-21 |
Opus Genetics Inc. | IRD | Bennett Jean Director |
272,874 | $0 | 272,874 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 5:31 pm |
N/A 2034-06-10 |
Ocuphire Pharma Inc. | OCUP | Rodgers Richard J Director |
76,324 | $0 | 274,332 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 5:30 pm |
N/A 2034-06-10 |
Ocuphire Pharma Inc. | OCUP | Pepose Jay Director |
76,324 | $0 | 215,639 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 5:28 pm |
N/A 2034-06-10 |
Ocuphire Pharma Inc. | OCUP | MANUSO JAMES S J Director |
76,324 | $0 | 167,218 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 5:27 pm |
N/A 2034-06-10 |
Ocuphire Pharma Inc. | OCUP | Gallagher Cam Director |
76,324 | $0 | 112,228 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 5:25 pm |
N/A 2034-06-10 |
Ocuphire Pharma Inc. | OCUP | Benton Susan Director |
76,324 | $0 | 175,204 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 5:23 pm |
N/A 2034-06-10 |
Ocuphire Pharma Inc. | OCUP | Ainsworth Sean Director |
76,324 | $0 | 123,539 (Direct) |
View |
| 2024-04-11 Option Award |
2024-04-15 4:11 pm |
N/A 2034-04-10 |
Ocuphire Pharma Inc. | OCUP | Pepose Jay Director |
80,000 | $0 | 187,315 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 6:37 pm |
N/A 2034-02-11 |
Ocuphire Pharma Inc. | OCUP | Jhaveri Nirav S. Chief Financial Officer |
350,000 | $0 | 350,000 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 6:35 pm |
N/A 2034-02-11 |
Ocuphire Pharma Inc. | OCUP | Jayagopal Ashwath Chief Scientific & Dev. Ofc. |
300,000 | $0 | 300,000 (Direct) |
View |